Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug development

A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau.

Healthcare Leaders Embrace Virtual Care and AI to Combat Staffing Crisis: Philips Future Health Index 2024

What You Should Know: – A new report by Philips, the Future Health Index 2024, paints a concerning picture of the healthcare industry struggling with

June 19, 2024

Opinion | Charting the Course: From Young Adult Leukemia Patient to Oncologist

Rosenthal is a lymphoma specialist. “Would you like to have a bone marrow biopsy today or tomorrow?” These are the only words I remember coming

December 4, 2023

Verastem Oncology submits NDA for ovarian cancer treatment

Verastem initiated the rolling NDA submission in May. Credit: Jo Panuwat D via Shutterstock. Verastem Oncology has concluded the rolling submission of a new drug

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.